SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (2297)1/10/2005 11:43:08 AM
From: software salesperson  Read Replies (1) of 3044
 
1/10/05 cc q&a

1. any front line revenue in V guidance ‘05? - - modest increase until compendia approval

2. can you get to ’06 profitability without another restructuring? - - yes

3. based on ’05 revenue and expense guidance, there would seem to be a lot of strategic alliance revenue needed to reach profitability target in ’05? Maybe a doubling of current levels? - - no; some new alliance revenue; some jnj milestones; some V ex-US royalties

4. what is the 2nd line V approval milestone amount? - - no direct answer

5. V revenue has shown 7-8% q over q growth the last 2 qs. You are projecting 6-7% for ’05. what are your 2nd line expectations? - - in 3rd line, we have a 40-50% share; need retreatment trial to raise 3rd line revenue; current 2nd line share is 20-30%; should be 40-50% after apex approval snda

6. re: expenses, will r&d scaledown be 25%? - - will be modest r&d decline; g&a and depreciation will drive overall expense decrease

Impressions:

With the only real news being a more intense focus on strategic alliances and a no go in the docetaxel combo nsclc trial, it remains a mystery why the need for a special early call. Speculative issues concerning mgmt. turnover, possible selling/buying of I, and acquisition/merger/sale of/by company were not raised. Their strategic plans remain in place, as does ’06 non-gaap profitability.

sales
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext